findmyKOL
Clinical trialNCT05597436No, longer, availableExpanded Access

Intermediate-Sized Expanded Access Study

SponsorSeelos Therapeutics, Inc.Amyotrophic Lateral Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This expanded access protocol is to provide access to the investigational product, SLS-005, to participants with ALS who are not eligible to participate in clinical trials.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Barrow Neurological Institute

    Phoenix, Arizona, United States

  • University of California, Irvine

    Orange, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • University of Colorado

    Aurora, Colorado, United States

  • Hospital for Special Care

    New Britain, Connecticut, United States

  • George Washington University

    Washington D.C., District of Columbia, United States

  • Holy Cross Hospital - Phil Smith Neuroscience Institute

    Fort Lauderdale, Florida, United States

  • Nova Southeastern University

    Fort Lauderdale, Florida, United States

  • Saint Alphonsus Regional Medical Center

    Boise, Idaho, United States

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

  • University of Maryland School of Medicine

    Baltimore, Maryland, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Sean M. Healey & Amg Center for Als Neurological Clinical Research Institute, Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Spectrum Health/corewell Health

    Grand Rapids, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Suny Upstate Medical University

    Syracuse, New York, United States

  • Lehigh Valley Hospital

    Allentown, Pennsylvania, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • Texas Neurology, P.A.-Neal Site:769

    Dallas, Texas, United States

  • Virginia Commonwealth University Clinical Research Unit

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Trehalose
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
—
Last update posted
2 Sept 2025
Registered enrollment
—
Registry id
NCT05597436

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.